I. McSherry

发表

ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors

O. Hoekstra, A. McGeoch, Deborah A. Smith, 2017 .

Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors

G. V. van Dongen, O. Hoekstra, H. Verheul, 2019, The Journal of Nuclear Medicine.

Endothelial cell Ca2+ increases are independent of membrane potential in pressurized rat mesenteric arteries.

I. McSherry, Kim A Dora, K. Dora, 2005, Cell calcium.

A Role for Heterocellular Coupling and EETs in Dilation of Rat Cremaster Arteries

J. Falck, W. Campbell, M. Hill, 2006, Microcirculation.

Safety, tolerability and pharmacokinetics (PK) of single and repeat nebulised doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy male subjects in a phase I study

A. Sousa, C. Rambaran, I. McSherry, 2013 .

Single‐Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese Subjects

K. Hacquoil, T. Hirama, I. McSherry, 2013, Clinical pharmacology in drug development.

Endothelium‐dependent Vasodilation in Myogenically Active Mouse Skeletal Muscle Arterioles: Role of EDH and K+ Channels

C. Triggle, M. Hill, H. Ding, 2009, Microcirculation.

EDHF-like responses in rat cremaster muscle arterioles

J. Falck, W. Campbell, M. Hill, 2005 .

Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates

L. McCarthy, I. McSherry, L. Haberer, 2013, European Journal of Clinical Pharmacology.